Skip to main content

Animations

The Michael J. Fox Foundation Launches 2019 Fox Trot 5K Run/Walk Series across the United States to Raise $1M for Parkinson's Disease Research

  • Runners and walkers of all ages, abilities and speeds are welcome
  • View the entire list of events and register at foxtrot.michaeljfox.org

NEW YORK (March 5, 2019) -- The Michael J. Fox Foundation for Parkinson's Research (MJFF) today announced the launch of its third annual Fox Trot 5K Run/Walk Series. The series of seven community events across the United States invites runners and walkers of all ages and abilities to lace up their sneakers in support of a cure for Parkinson's disease. The 2019 Fox Trot 5K season will officially kick off this Sunday, March 10 at the first event in Los Angeles, California.

"Our Fox Trot 5K Series is another example of the Foundation's commitment to uniting the Parkinson's community to accelerate a cure for the disease," said Deborah W. Brooks, MJFF's co-founder and executive vice chairman. "We continue to expand the Series with the help of dedicated individuals on the ground who are instrumental in raising awareness and funds in their communities. Those who live with Parkinson's or love someone who does are joining us to move toward our urgent goal to end Parkinson's."

Established in 2017, MJFF's Fox Trot 5K Series has united more than 4,000 community members and raised over $1 million to support the high-impact research programs of the Foundation. This year, the Series aims to double its lifetime fundraising total with a 2019 goal of $1 million -- 100 percent of which will go directly to MJFF's pursuit of a Parkinson's cure. The 2019 event schedule is as follows:

Participants are encouraged to register early. Registration is $40 per adult and $20 per child under age 13. All online registrants will receive a Fox Trot 5K Series t-shirt and participants who fundraise at least $250 through an official fundraising page also receive a Fox Trot 5K Series baseball cap. Registration is now open at foxtrot.michaeljfox.org. For those unable to attend, the Foundation welcomes donations to the Fox Trot 5K Series to help meet its $1 million fundraising goal.

The signature Fox Trot 5K Series supports the mission of The Michael J. Fox Foundation to work urgently to speed development of better treatments and a much-needed cure for the estimated 6 million people worldwide living with Parkinson's disease. The 2019 Fox Trot 5K Run/Walk Series is presented by American Airlines and sponsored in part by Acorda Therapeutics, Inc.

Register for any Fox Trot 5K event or donate to support the Series at foxtrot.michaeljfox.org.

###

About The Michael J. Fox Foundation for Parkinson's Research
As the world's largest nonprofit funder of Parkinson's research, The Michael J. Fox Foundation is dedicated to accelerating a cure for Parkinson's disease and improved therapies for those living with the condition today. The Foundation pursues its goals through an aggressively funded, highly targeted research program coupled with active global engagement of scientists, Parkinson's patients, business leaders, clinical trial participants, donors and volunteers. In addition to funding more than $800 million in research to date, the Foundation has fundamentally altered the trajectory of progress toward a cure. Operating at the hub of worldwide Parkinson's research, the Foundation forges groundbreaking collaborations with industry leaders, academic scientists and government research funders; increases the flow of participants into Parkinson's disease clinical trials with its online tool, Fox Trial Finder; promotes Parkinson's awareness through high-profile advocacy, events and outreach; and coordinates the grassroots involvement of thousands of Team Fox members around the world.

For more information, visit us on the web, Facebook, Twitter, LinkedIn and Pinterest.

Media Contact:
Allison Boiles
The Michael J. Fox Foundation
212-509-0995
aboiles@michaeljfox.org

We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.